More than 200 companies advance trial management with veeva ctms

Biopharmas use leading ctms for improved trial efficiency and collaboration pleasanton, calif. , jan. 29, 2025 /prnewswire/ -- veeva systems (nyse: veev) today announced that more than 200 companies – including 17 of the top 20 biopharmas – use veeva ctms to execute faster, more efficient trials.
VEEV Ratings Summary
VEEV Quant Ranking